Administrer le juste prix des médicaments: entre gouvernement des valeurs et gouvernement des conduites

Étienne Nouguez

Regards croisés sur l'économie, 2023, vol. n° 32, issue 1, 239-247

Abstract: The prices of reimbursed drugs have been negotiated in France by an interministerial committee with pharmaceutical companies since the mid-1990s. This price control has allowed the public authorities to govern the values conferred on drugs by articulating several conceptions of social justice. Simultaneously, the Comité économique des produits de santé (CEPS) has also sought to govern the behaviours of companies and prescribers, by adjusting prices to take account of market dynamics. The result is an architecture of drug prices whose social justice and market accuracy are subject to multiple controversies.

Date: 2023
References: Add references at CitEc
Citations:

Downloads: (external link)
http://www.cairn.info/load_pdf.php?ID_ARTICLE=RCE_032_0239 (application/pdf)
http://www.cairn.info/revue-regards-croises-sur-l-economie-2023-1-page-239.htm (text/html)
restricted

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:cai:rcedec:rce_032_0239

Access Statistics for this article

More articles in Regards croisés sur l'économie from La Découverte
Bibliographic data for series maintained by Jean-Baptiste de Vathaire ().